Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

286.89
Delayed Data
As of Apr 25
 +10.03 / +3.62%
Today’s Change
205.42
Today|||52-Week Range
307.33
+9.83%
Year-to-Date
Nasdaq Tops 6,000 in Busy Day of Milestones for Wall Street
Apr 25 / TheStreet.com - Paid Partner Content
Stock Futures See More Gains on a Stream of Positive Earnings
Apr 25 / TheStreet.com - Paid Partner Content
First Quadrant L P Buys Williams, LyondellBasell Industries NV, Zoetis, Sells Verizon...
Apr 25 / GuruFocus News - Paid Partner Content
Earnings Scheduled For April 25, 2017
Apr 25 / Benzinga - Paid Partner Content
Lilly (LLY) Tops Q1 Earnings, Misses Sales, Shares Down
Apr 25 / Zacks.com - Paid Partner Content
3 Key Factors to Look Out for in Biogen's Q1 Results
Apr 24 / Zacks.com - Paid Partner Content
Stocks Hold at Highs as Dow, S&P 500 Enjoy Best Two-Day Stretch of 2017
Apr 25 / TheStreet.com - Paid Partner Content
Biogen Hopes New Spine Drug Data Convinces Insurers to Loosen Patient Access, Boost S...
Apr 24 / TheStreet.com - Paid Partner Content
Biogen (BIIB) Q1 Earnings & Sales Top, Spinraza Sales Strong
Apr 25 / Zacks.com - Paid Partner Content
Drug Stocks Q1 Earnings Releases on Apr 25: LLY, BIIB, NVS
Apr 24 / Zacks.com - Paid Partner Content
Meritage Portfolio Management Buys Lam Research, Thor Industries, Gibraltar Industrie...
Apr 25 / GuruFocus News - Paid Partner Content
Spiros Segalas Sells American Tower, Biogen, Regeneron, Disney
Apr 21 / GuruFocus News - Paid Partner Content
Endo Pops After Parkinson's Tests, IDexx Continues Fall, Biogen Higher: Tuesday's Bio...
Apr 25 / TheStreet.com - Paid Partner Content
What's in Store for Biogen (BIIB) this Earnings Season?
Apr 20 / Zacks.com - Paid Partner Content
Caterpillar Hauls Dow Sharply Higher, Nasdaq Tops 6,000 for First Time
Apr 25 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: FDA CRL Hits Incyte, Pipeline Setbacks Weigh on OncoMed
Apr 19 / Zacks.com - Paid Partner Content
Biogen (BIIB) Beats on Q1 Earnings and Revenue
Apr 25 / Zacks.com - Paid Partner Content
Bristol-Myers and Nordic Ink Biomarker Collaboration Deal
Apr 18 / Zacks.com - Paid Partner Content
Intermede Investment Partners Ltd Buys Rockwell Collins, S&P Global, Biogen, Sells B/...
Apr 25 / GuruFocus News - Paid Partner Content
Biogen to License Alzheimer Candidate from Bristol-Myers
Apr 17 / Zacks.com - Paid Partner Content
Biogen Spine Disease Drug Sales Strong in First Quarter Since Commercial Launch
Apr 25 / TheStreet.com - Paid Partner Content